Pharmaceuticals (Therapeutic Medications)
- Code of Federal Regulations:
- First-Class Airman Medical Certificate: 67.113(b)(c)
- Second-Class Airman Medical Certificate: 67.213(b)(c)
- Third-Class Airman Medical Certificate: 67.313(b)(c)
The applicant should provide history and treatment, type of medication, purpose, and duration of use. Issuance of a medical certificate is dependant on current blood pressure levels and whether the applicant is taking anti-hypertensive medication. The Examiner should also determine if the applicant has a history of complications, adverse reactions to therapy, hospitalization, etc.
- Medications acceptable to the FAA for treatment of hypertension in airmen include all Food and Drug Administration (FDA) approved diuretics, alpha-adrenergic blocking agents, beta-adrenergic blocking agents, calcium channel blocking agents, angiotension converting enzyme (ACE inhibitors) agents, and direct vasodilators.
- Not acceptable to the FAA:
- centrally acting agents (such as but not limited to clonidine, reserpine, guanethidine, guanadrel, guanabenz, and methyldopa).
- A combination of beta-adrenergic blocking agents used with insulin, meglitinides, or sulfonylureas.
- The Examiner must defer issuance of a medical certificate to any applicant whose hypertension has not been evaluated, who uses unacceptable medications, whose medical status is unclear, whose hypertension is uncontrolled, who manifests significant adverse effects of medication, or whose certification has previously been specifically reserved to the FAA.